<DOC>
	<DOCNO>NCT00167154</DOCNO>
	<brief_summary>The purpose trial investigate efficacy risperidone adjunct antidepressant treatment acute management suicidality episode major depressive disorder .</brief_summary>
	<brief_title>Risperidone Suicidality Major Depressive Disorder</brief_title>
	<detailed_description>Using double blind , placebo-controlled design , subject diagnose current episode major depressive disorder ( define DSM-IV criterion support Mini International Neuropsychiatric Interview ) , severe suicidality despite currently take antidepressant , enrol eight-week study . The treatment initiate randomize patient receive risperidone placebo addition antidepressant patient already take . The clinical efficacy evaluate 4 day , weekly 4 week , every week 4 week efficacy measure . During eight-week study , treatment risperidone placebo continue high effective dosage ( 2 mg per day ) . The dose antidepressant change study .</detailed_description>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<mesh_term>Risperidone</mesh_term>
	<criteria>1 . 1960 year age 2 . Diagnosis major depressive disorder , currently severe suicidality 3 . A total score MontgomeryAsberg Depression Rating Scale ( MADRS ) =/ &gt; 25 suicide subscore =/ &gt; 4 4 . Currently take antidepressant therapeutic dose longer 3 week 5 . In good physical health 1 . Depression without suicidality 2 . Presence major psychiatric condition major depressive disorder , bipolar disorder , schizophrenia , anxiety disorder ( except generalize anxiety disorder ) 3 . Depressive symptom induce alcohol substance abuse 4 . Psychotic feature predominant initial evaluation 5 . Unstable major medical illness , cardiac disease diabetes 6 . Female subject pregnant , breastfeeding , , childbearing potential , unwilling use adequate birth control measure</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>suicidality</keyword>
	<keyword>antipsychotic</keyword>
	<keyword>antidepressant</keyword>
	<keyword>treatment</keyword>
</DOC>